Sonnet BioTherapeutics Holdings Overview

Sonnet BioTherapeutics Holdings Operating Income

Operating Income for SONN.

Quarterly Operating Income

$-4958817.00

↑ 56.26% YoY

As of Sep 30, 2025

Annual Operating Income (TTM)

$-15844115.00

↑ 33.71% YoY

Trailing 12 months ending Sep 30, 2025

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin